2.43%XLF 15.10 
10.30%QQQQ 31.32 0.63%
The Global Business News Leader | Saturday, 11 Oct 2008
- EQUITY MARKETS
- BONDS AND RATES
- FOREX
- COMMODITIES
- LANGUAGES
- FUNDS
- RETIREMENT
- TAXES
- INSURANCE
- LANGUAGES
- MOVIE
- MUSIC
- TV
- CELEBRITIES
- LANGUAGES
GILEAD SCIENCES
GILD (NASDAQ)
$ 37.47 
Change: -2.57 -6.86% | Volume: 25,102,158
Change: -2.57 -6.86% | Volume: 25,102,158
Sponsored by 
GILEAD SCIENCES - Fundamental Profile
Company Information
| Ticker Symbol: | GILD |
|---|---|
| Exchange: | NASD |
| Contact Info: | 333 Lakeside Drive Foster City CA 94404 650-574-3000 |
| CEO/President: | John C. Martin |
| Industry: | Medical - Biomedical / Standard Industry Code: 2836 |
| Description: | Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer. They have expertise in liposomal drug delivery technology, a technology that the company uses to develop drugsthat are safer, easier for patients to tolerate and more effective. |
Share Information
| Shares Outstanding: | 922,470 (000) | Market Value: | 36,833,400 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 90.57% | Number of Inst.Shareholders: | 3.00% |
| Last Quarter Sales: | 1278.13 ($Mil.) | Last Quarter Net Income: | 442.83 ($Mil.) |
| Last Quarter EPS: | 0.47 | P/E Ratio: | 22 |
| Most Recent Earnings: | 0.49 on 07/17/08 | Earnings Per Share: | 1.80 |
| Most Recent Split: | 2-1 on 06/25/07 | Annual Dividend Rate: | 0 |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
Most Popular 
GILD
Companies
IBT
- AIG Units Party, Luxury Resort Conference Upsets Watchdogs
- Ahead of the Bell: Morgan Stanley plunges
- Gold bullion and stocks shine during one of most volatile days
- Harley revs up cooler image with supermodel Miller
- Morgan Stanley shares sink on worries about future
- SEC head asks for reins on credit default swaps
- Harmony leads global gold pack
- W Magazine Angelina Jolie: I bought Maddox his first knife
- Brad Pitts exclusive photos of Angelina Jolie breastfeeding appears on W Magazine Cover
- Sarah Palin is Princess Dianas and Roosevelts distant cousin
- Angelina Jolie: My Twins Are Totally Sweet
- Ahead of Troopergate Report, NYT Says Official Pressured Indirectly
- Playboy Hugh Hefner New Girlfriends: Karissa and Kristina Shannon, Amy Leigh Andrews
- Hugh Heffner: Done With Holly Madison, Moves onto Karissa and Kristina Shannon
Top Competitors
| AMGEN |  |
-10.70 | 50.26 |
| GILEAD SCIENCES | |
-19.00 | 40.04 |
| GENENTECH INC |  |
+0.80 | 78.75 |
| CELGENE CP | |
-22.80 | 56.55 |
| BIOGEN IDEC INC | |
-30.50 | 44.76 |
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives